Meet the expert: advances in personalized therapy for metastatic breast cancer

Acquisizione competenze di sistema:Breast cancer is the most common tumor in the female population, with approximately 55,000 new cases diagnosed each year in italy. advancements in diagnostic techniques, the availability of new drugs, and a multidisciplinary approach have significantly increased cure rates. However, metastatic disease remains incurable, requiring a tailored approach to antitumor therapy that takes multiple factors into account. the main objective of the meet the expert meeting is to focus on the latest therapeutic advancements in hr+/her2- metastatic breast cancer (mbc), from clinical trial protocols to currently available real-world data.